BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18569640)

  • 1. Non-Hodgkin lymphoma expressing high levels of the danger-signalling protein HMGB1.
    Meyer A; Staratschek-Jox A; Springwald A; Wenk H; Wolf J; Wickenhauser C; Bullerdiek J
    Leuk Lymphoma; 2008 Jun; 49(6):1184-9. PubMed ID: 18569640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of high mobility group box 1 (HMGB1) expression in patients with colorectal cancer.
    Ueda M; Takahashi Y; Shinden Y; Sakimura S; Hirata H; Uchi R; Takano Y; Kurashige J; Iguchi T; Eguchi H; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Anticancer Res; 2014 Oct; 34(10):5357-62. PubMed ID: 25275029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas.
    Thomázy VA; Luthra R; Uthman MO; Davies PJ; Medeiros LJ
    J Mol Diagn; 2002 Nov; 4(4):201-8. PubMed ID: 12411587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expressions and clinical significance of high mobility group box-1 mRNA and protein in laryngeal squamous cell carcinoma tissues and serum].
    Guo Y; Liu Y; Tan PQ; Li G; Su ZW; Tian YQ; Qiu YZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jun; 47(6):487-90. PubMed ID: 22932142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of high mobility group box-1 in the lung tissue and serum of patients with pulmonary tuberculosis].
    Yang XM; Yang H
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):497-500. PubMed ID: 24262084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo.
    Dong YD; Cui L; Peng CH; Cheng DF; Han BS; Huang F
    Oncol Rep; 2013 Jan; 29(1):87-94. PubMed ID: 23042506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
    Zhang C; Cui GH; Liu F; Wu QL; Chen Y
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
    Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
    BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies.
    Lossos IS; Czerwinski DK; Wechser MA; Levy R
    Leukemia; 2003 Apr; 17(4):789-95. PubMed ID: 12682639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells.
    Moriai R; Asanuma K; Kobayashi D; Yajima T; Yagihashi A; Yamada M; Watanabe N
    Anticancer Res; 2001; 21(1B):595-600. PubMed ID: 11299811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of HMGB1 in cancerous and inflammatory effusions.
    Winter N; Meyer A; Richter A; Krisponeit D; Bullerdiek J
    Anticancer Res; 2009 Dec; 29(12):5013-7. PubMed ID: 20044610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas.
    Völp K; Brezniceanu ML; Bösser S; Brabletz T; Kirchner T; Göttel D; Joos S; Zörnig M
    Gut; 2006 Feb; 55(2):234-42. PubMed ID: 16118352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of high mobility group box chromosomal protein 1 in peripheral blood of patients with rheumatoid arthritis].
    Zuo XX; Zhou YO; Gong YH; Wang YP; Tang DL; Xiao XZ
    Zhonghua Nei Ke Za Zhi; 2007 Jul; 46(7):547-50. PubMed ID: 17959074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis.
    Kawabata H; Setoguchi T; Yone K; Souda M; Yoshida H; Kawahara K; Maruyama I; Komiya S
    Spine (Phila Pa 1976); 2010 May; 35(11):1109-15. PubMed ID: 20195207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements.
    Jardin F; Buchonnet G; Parmentier F; Contentin N; Leprêtre S; Lenain P; Picquenot JM; Laberge S; Bertrand P; Stamatoullas A; D'Anjou J; Tilly H; Bastard C
    Leukemia; 2002 Nov; 16(11):2318-25. PubMed ID: 12399978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation.
    Klapper W; Krams M; Qian W; Janssen D; Parwaresch R
    Br J Cancer; 2003 Aug; 89(4):713-9. PubMed ID: 12915884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.
    Li J; Xie H; Wen T; Liu H; Zhu W; Chen X
    J Rheumatol; 2010 Apr; 37(4):766-75. PubMed ID: 20110525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative detection of telomere binding factor 2 gene expression in non-Hodgkin lymphoma with a real-time reverse transcription-polymerase chain reaction assay].
    Qian WB; Meng HT; Jin J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 33(5):416-20. PubMed ID: 15476325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of high mobility group box chromosomal protein 1 in eosinophilic chronic rhinosinusitis with nasal polyps.
    Chen D; Mao M; Bellussi LM; Passali D; Chen L
    Int Forum Allergy Rhinol; 2014 Jun; 4(6):453-62. PubMed ID: 24504744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing between proliferating nodal lymphoid blasts in chronic myelogenous leukemia and non-Hodgkin lymphoma: report of three cases and detection of a bcr/abl fusion signal by single-cell analysis.
    Yashima-Abo A; Satoh T; Abo T; Aoki Y; Kowata S; Ito S; Ishida Y; Fujiwara H; Maesawa C; Masuda T
    Pathol Int; 2005 May; 55(5):273-9. PubMed ID: 15871725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.